To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Lilly's six existing Gateway ...

Eli Lilly (NYSE:LLY) on Friday reported plans to acquire Adverum Biotechnologies (NASDAQ:ADVM) and its lead gene therapy candidate, Ixo-vec, sending Adverum shares soaring in premarket trading. Under ...

MOBILE, Ala. (WALA) - Halloween is coming soon, so it’s time to get ‘crafty’ with Lynn Lilly of Craftbox Girls. Lynn is the perfect DIY expert to inspire creative trick and treat inspiration and some ...

Lilly Aspell is Scottish-born actress famous for portraying Young Diana (Gal Gadot) in Wonder Woman and Wonder Woman 1984 . Born in Kilmarnock, Ayrshire, Lilly is a keen equestrian and combines both ...

Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

President Donald Trump’s vow to slap 100% tariffs on pharmaceutical companies unless they manufacture in the U.S. didn’t have the knee-jerk market reaction that might be expected.

While Eli Lilly is rethinking its biotech incubator plans in Europe, the Big Pharma has gone ahead and opened its San Diego site. The Gateway Labs are co-working spaces for researchers that also act ...

Eli Lilly and Company (NYSE: LLY) shares are trading lower after the company ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it ...

Eli Lilly & Co. halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons it didn’t disclose. Lilly closed the trial on ...